Cargando…
CRKL is a critical target of Hh‐GLI2 pathway in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is one of the important components of non‐small‐cell lung cancer (NSCLC) and leads to many deaths every year. During the initiation and progression of the LUAD, the Hh‐GLI2 pathway plays critical roles. Several components of this pathway have been shown to be amplified or...
Autores principales: | Liu, Xiaoming, Hu, Yan, Yu, Bentong, Peng, Kai, Gan, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256351/ https://www.ncbi.nlm.nih.gov/pubmed/34076957 http://dx.doi.org/10.1111/jcmm.16592 |
Ejemplares similares
-
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma
por: An, Rong, et al.
Publicado: (2016) -
Crk and CrkL as Therapeutic Targets for Cancer Treatment
por: Park, Taeju
Publicado: (2021) -
Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer
por: Kim, Young H., et al.
Publicado: (2009) -
Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
por: Kaushal, Jyoti B., et al.
Publicado: (2021) -
MiR-378 and MiR-1827 Regulate Tumor Invasion, Migration and Angiogenesis in Human Lung Adenocarcinoma by Targeting RBX1 and CRKL, Respectively
por: Ho, Chai San, et al.
Publicado: (2018)